Investing
Top Active Trader Alert Stocks (AFFY, CLDX, CRUS, GMCR, NFLX, NOVL)
Published:
Last Updated:
Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves in shares of Affymax, Inc. (NASDAQ: AFFY), Celldex Therapeutics, Inc. (NASDAQ: CLDX), Cirrus Logic, Inc. (NASDAQ: CRUS), Gold Mountain Coffee Roasters Inc. (NASDAQ: GMCR), Netflix, Inc. (NASDAQ: NFLX), and Novell, Inc. (NASDAQ: NOVL).
Affymax, Inc. (NASDAQ: AFFY) is up 7% to $6, relative to a 52-week range of $4.90 – $26.20.
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is up 7% premarket to $4.95, relative to a 52-week range of $2.91 – $9.49. The gain comes after news of successful phase II clinincal trails of the company’s brain cancer drug.
Cirrus Logic, Inc. (NASDAQ: CRUS) is up 5% to $14.52 after being upgraded by Jefferies to “buy.”
Gold Mountain Coffee Roasters Inc. (NASDAQ: GMCR) is up 11.2% on heavy volume premarket after friday’s spike, which came as a result of announced accounting errors within the company.
Netflix, Inc. (NASDAQ: NFLX) is up $3.00 premarket after announcing a new plan which will allow users to stream programming over the internet for $7.99 a month. Shares of NFLX are at $176, relative to a 52-week range of $48.52-$184.74.
Novell, Inc. (NASDAQ: NOVL) has just announced it has agreed to be acquired by Attachmate Corporation. The stock is up $0.41 to $6.00, relative to a 52-week range of $3.84 – $6.53.
-Michael B. Sauter
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
